Skip to Content

Edoxaban

In the US, Edoxaban (edoxaban systemic) is a member of the drug class factor Xa inhibitors and is used to treat Atrial Fibrillation, Deep Vein Thrombosis, Prevention of Thromboembolism in Atrial Fibrillation and Pulmonary Embolism.

US matches:

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0480449-70-5

Chemical Formula

C24-H30-Cl-N7-O4-S

Molecular Weight

548

Therapeutic Category

Anticoagulant agent

Chemical Name

N-(5-Chloropyridin-2-yl)-N'-[(1S,2R,4S)-4-(N,N-dimetylcarbamoyl)-2-(5-metyl-4,5,6,7-tetrahydro[1,3]tiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl]oxamide (WHO)

Foreign Names

  • Edoxabanum (Latin)
  • Edoxaban (German)
  • Édoxaban (French)
  • Edoxabán (Spanish)

Generic Names

Brand Names

  • Lixiana
    Daiichi Sankyo, Japan; Daiichi Sankyo, Switzerland; Daiichi Sankyo, Germany; Daiichi Sankyo UK, United Kingdom
  • Savaysa
    Daiichi Sankyo, United States

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide